Telehealth GLP-1 prescription checklist: what to verify first

Check that the clinician is licensed in your state and that the service lists a real business address and support contact. Make sure there is a clear way to reach them after the visit for side effects, refills, or paperwork. Ask how follow-ups work and how often they reassess your health and goals. If you cannot identify who is prescribing or how to contact them, treat that as a red flag.

Before your appointment, write down your current medicines, supplements, and any allergies, plus your most recent weight and height. Include prior GLP-1 use (Ozempic, Wegovy, Mounjaro, Zepbound, or pills) and whether you used branded or compounded versions. Share relevant diagnoses you already have, especially heart, kidney, blood-pressure conditions, prediabetes, or past stroke/heart attack if applicable. Do not rely on memory during the visit; a clean list helps the prescriber make safer decisions.

Telehealth should still include basic screening, like reviewing your medical history and any recent labs or vitals you can provide. Ask what they require before starting or continuing therapy and how they monitor progress over time. Clarify how they handle side effects and when they want you to seek in-person care. If the process feels like a quick form with no clinical review, pause and consider a different provider.

Ask for the exact medication name and form (for example, injection pen, vial, or daily pill) and confirm what pharmacy channel will dispense it. If you are prescribed a pill, make sure you understand the dosing instructions tied to that product. For example, Wegovy pill (oral semaglutide 25 mg) must be taken first thing in the morning with a small sip of water, at least 30 minutes before food, drinks, or other oral medicines. Foundayo (orforglipron) is a once-daily GLP-1 pill that can be taken any time of day with no fasting or water restrictions.

Ask the clinic whether they handle prior authorization and what information they need from you to try. If you have Medicare Part D, ask whether the Medicare GLP-1 Bridge demonstration may apply and what documentation is needed for prior authorization; eligibility rules are specific. If you are self-pay, compare official manufacturer channels and confirm pricing “at the time of writing,” since programs change often. TrumpRx.gov may list current manufacturer self-pay options and route you to the maker’s channel, but it is not insurance.

If a telehealth service offers compounded GLP-1s, ask where the prescription is being filled, what they are compounding, and how they handle quality and follow-up. Avoid any seller advertising unapproved products as if they are the real thing; for example, retatrutide is not approved as of the publish date and is not legally prescribable outside clinical trials. Do not buy “research-use” peptides online for self-injection. When in doubt, ask your pharmacist to confirm what you were dispensed and who made it.